PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 1329230-8 1992 Therefore, teniposide is an effective agent against brain metastases of SCLC and is suitable for palliation of these patients. Teniposide 11-21 SCLC1 Homo sapiens 72-76 1411638-4 1992 The substantial antitumor activity of teniposide is comparable with that of etoposide, and clinical interest was rekindled when it was shown to have considerable activity against small cell lung cancer (SCLC). Teniposide 38-48 SCLC1 Homo sapiens 203-207 1411638-8 1992 Finally, it is suggested that with new routes of administration and improved formulations, teniposide may be expected to play a significant role in the treatment of malignant lymphomas, SCLC, and pediatric lymphocytic leukemia and neuroblastoma. Teniposide 91-101 SCLC1 Homo sapiens 186-190 7884426-2 1995 PURPOSE: Here we report the results of a phase II study of teniposide, one of the most active drugs against small-cell lung cancer (SCLC), in patients with brain metastases. Teniposide 59-69 SCLC1 Homo sapiens 132-136 7884426-3 1995 PATIENTS AND METHODS: Patients with SCLC who presented with brain metastases at diagnosis (n = 11) or during follow-up evaluation after treatment (n = 69) were treated with teniposide at a dose of 150 mg/m2 intravenously on days 1, 3, and 5 at 3-week intervals in an outpatient setting. Teniposide 173-183 SCLC1 Homo sapiens 36-40 7884426-11 1995 CONCLUSION: Teniposide is active against brain metastases of SCLC. Teniposide 12-22 SCLC1 Homo sapiens 61-65 3815721-1 1987 To determine whether there is any difference between the two epipodophyllotoxin derivatives etoposide and teniposide in their therapeutic effect in small cell carcinoma of the lung (SCCL), they were compared against five human SCCL cell lines in vitro. Teniposide 106-116 SCLC1 Homo sapiens 182-186 2549879-2 1989 Of new drugs, teniposide and carboplatin have a significant activity against SCLC, however, the usefulness of these drugs must be determined in the comparative fashion with their mother compounds. Teniposide 14-24 SCLC1 Homo sapiens 77-81